Annual report pursuant to Section 13 and 15(d)

EQUITY TRANSACTIONS (Tables)

v3.22.2
EQUITY TRANSACTIONS (Tables)
12 Months Ended
Mar. 31, 2022
Equity [Abstract]  
Summary of warrant activity
                               
    Fiscal Year Ended March 31,  
    2022     2021  
    Warrants     Weighted
Average
Exercise Price
    Warrants     Weighted
Average
Exercise Price
 
Outstanding, beginning of year     1,991,973     $ 5.23       2,021,368     $ 5.21  
Granted         $ N/A           $ N/A  
Exercised     (1,206,721 )   $ 2.21           $ N/A  
Cancelled/Forfeited     (208,514 )   $ 6.11       (29,395 )   $ 91.17  
Outstanding, end of year     576,738     $ 11.21       1,991,973     $ 5.23  
Exercisable, end of year     576,738     $ 11.21       1,991,973     $ 5.23  
Weighted average estimated fair value of warrants granted           $ N/A             $ 1.22  
Summary of warrant activity exercisable and outstanding
                                       
      Warrants Outstanding       Warrants Exercisable  
Range of
Exercise Prices
    Number
Outstanding
      Weighted
Average
Remaining
Life (Years)
      Weighted
Average
Exercise Price
      Number
Outstanding
      Weighted
Average
Exercise Price
 
$2.75 or Below     326,753       2.78     $ 2.01       326,753     $ 2.01  
$16.50 - $59.25     249,985       0.43     $ 23.24       249,985     $ 23.24  
      576,738                       576,738          
Options outstanding that have vested and are expected to vest
                       
    Number of
Shares
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term in
Years
 
Vested     267,221     $ 2.51       8.21  
Expected to vest     1,398,727     $ 2.27       9.17  
Total     1,665,948                  
Summary of stock options outstanding
                           
    Fiscal Year Ended March 31,  
    2022     2021  
    Options     Weighted
Average
Exercise Price
    Options     Weighted
Average
Exercise Price
 
Outstanding, beginning of year   844,089     $ 3.07     51,124     $ 44.12  
Granted   941,188     $ 2.48     1,011,860     $ 1.71  
Exercised   (11,562 )   $ 2.45     (15,896 )   $ 1.28  
Cancelled/Forfeited   (107,767 )   $ 9.66     (202,999 )   $ 6.76  
Outstanding, end of year   1,665,948     $ 2.31     844,089     $ 3.07  
Exercisable, end of year   267,221     $ 2.51     58,954     $ 20.06  
Weighted average estimated fair value of options granted         $ 2.41           $ 1.58  

 

Detail of options outstanding and exercisable by exercise price
                                           
          Options Outstanding       Options Exercisable  
  Exercise Prices       Number
Outstanding
      Weighted
Average
Remaining
Life (Years)
      Weighted
Average
Exercise
Price
      Number
Outstanding
      Weighted
Average
Exercise
Price
 
  $1.28 - $1.68       1,154,114       9.39 years     $ 1.38       193,526     $ 1.33  
  $2.45 - $5.17       508,654       9.09 years     $ 3.91       70,515     $ 2.52  
  $57.00 - $142.50       3,180       1.43 years     $ 84.50       3,180     $ 84.50  
          1,665,948                       267,221          
Schedule of stock-based compensation
               
    Fiscal Year Ended  
    March 31, 2022     March 31, 2021  
Vesting of restricted stock units   $ 150,000     $ 175,000  
Vesting of restricted shares issued for services     16,500       1,500  
Vesting of stock options     584,121       602,921  
Total Stock-Based Compensation   $ 750,621     $ 779,421